This case highlights the critical need for a high index of suspicion for EuDKA in patients taking SGLT2 inhibitors, even with only modest hyperglycemia, and underscores the importance of prompt intervention, including consideration of early hemodialysis, when standard therapies for metabolic acidosis fail. Here, SLC5A2 is linked to Hyperglycemia.